premenopausal patients were randomized to cyclophosphamide , methotrexate , and fluorouracil ( 5-fu ) ( cmf ) , cyclophosphamide , methotrexate , 5-fu , and prednisone ( cmfp ) , or cyclophosphamide , methotrexate , 5-fu , prednisone , and tamoxifen ( cmfpt ) .
C0055985
cmfp
C0025677
methotrexate